research use only

AZD2098 CCR antagonist

Cat.No.S6555

AZD2098 is a potent and bioavailable CCR4 receptor antagonist with pIC50 of 7.8.
AZD2098 CCR antagonist Chemical Structure

Chemical Structure

Molecular Weight: 334.18

Quality Control

Chemical Information, Storage & Stability

Molecular Weight 334.18 Formula

C11H9Cl2N3O3S

Storage (From the date of receipt) 3 years -20°C powder
CAS No. 566203-88-1 -- Storage of Stock Solutions

Synonyms N/A Smiles COC1=NC=CN=C1NS(=O)(=O)C2=C(C(=CC=C2)Cl)Cl

Solubility

In vitro
Batch:

DMSO : 67 mg/mL (200.49 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : 4 mg/mL

Water : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

Targets/IC50/Ki
rat CCR4 [1]
8(pIC50)
mouse CCR4 [1]
8(pIC50)
hCCR4 [1]
7.8(pIC50)
dog CCR4 [1]
7.6(pIC50)
In vitro

AZD2098 demonstrates good selectivity for the CCR4 receptor when screened in-house against a range of other chemokine receptors (CXCR1 and CXCR2, CCR1, CCR2b, CCR5, CCR7, and CCR8; all inactive at 10 μM) and little or no activity when screened against a large panel of receptors and enzymes[1].

References

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.

Signaling Pathway Map